Ignite Creation Date:
2025-12-24 @ 4:14 PM
Ignite Modification Date:
2025-12-24 @ 4:14 PM
Study NCT ID:
NCT06746766
Status:
RECRUITING
Last Update Posted:
2024-12-24
First Post:
2024-12-09
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Registry Study on Rare Cancers in Korea
Sponsor:
Yonsei University
Organization:
Study Overview
Official Title:
Registry Study on Rare Cancers in Korea
Status:
RECRUITING
Status Verified Date:
2024-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
rarecancer
Brief Summary:
This study aims to determine the participation rate of patients with registered rare cancers in clinical research.
Detailed Description:
Data collection includes:
* Clinical characteristics (diagnosis, treatment information, primary/metastatic sites, staging, gender/age)
* Survival information (diagnosis date, recurrence date, death date, disease progression)
* Pathological information (diagnosis, genomic information)
* Clinical characteristics (diagnosis, treatment information, primary/metastatic sites, staging, gender/age)
* Survival information (diagnosis date, recurrence date, death date, disease progression)
* Pathological information (diagnosis, genomic information)
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| 4-2024-1207 | OTHER | Severance Hospital, IRB | View |